Full Text View
Tabular View
No Study Results Posted
Related Studies
Ritanserin in Treatment of Cocaine Dependence - 1
This study has been completed.
Study NCT00000187   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes

September 20, 1999
August 16, 2005
July 1992
 
  • Cocaine use
  • Cocaine craving
Same as current
Complete list of historical versions of study NCT00000187 on ClinicalTrials.gov Archive Site
 
 
 
Ritanserin in Treatment of Cocaine Dependence - 1
Ritanserin in Treatment of Cocaine Dependence

The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.

 
Phase II
Interventional
Treatment
Cocaine-Related Disorders
Drug: Ritanserin
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
 
 

Please contact site for information.

Male
28 Years to 47 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000187
 
NIDA-00144-1, K20-00144-1
National Institute on Drug Abuse (NIDA)
University of Pennsylvania
Principal Investigator: James Cornish, M.D. University of Pennsylvania
National Institute on Drug Abuse (NIDA)
October 1994

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP